Triple

T5872908
Position Surface form Disambiguated ID Type / Status
Subject Pharmacovigilance Risk Assessment Committee E130559 entity
Predicate legalBasis P125 FINISHED
Object Regulation (EC) No 726/2004 E23503 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 726/2004 | Statement: [Pharmacovigilance Risk Assessment Committee, legalBasis, Regulation (EC) No 726/2004]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Regulation (EC) No 726/2004
Context triple: [Pharmacovigilance Risk Assessment Committee, legalBasis, Regulation (EC) No 726/2004]
  • A. Regulation (EC) No 726/2004 chosen
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • B. Regulation (EC) No 851/2004
    Regulation (EC) No 851/2004 is the EU law that established the European Centre for Disease Prevention and Control and defined its mandate, structure, and functions in coordinating infectious disease surveillance and control across member states.
  • C. Regulation (EC) No 1394/2007
    Regulation (EC) No 1394/2007 is the core EU legal framework governing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies, setting specific rules for their authorization, supervision, and pharmacovigilance.
  • D. Regulation (EC) No 294/2008
    Regulation (EC) No 294/2008 is the EU legislative act that established the European Institute of Innovation and Technology and set out its mission, structure, and operating framework.
  • E. Regulation (EC) No 45/2001
    Regulation (EC) No 45/2001 is an EU law that sets out data protection rules for the processing of personal data by EU institutions and bodies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085047dc8190af24e311edad3c07 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c035f99b788190b5b06d83b9499bfa completed March 22, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69c107fd138c819092096f473be3e4cf completed March 23, 2026, 9:29 a.m.
Created at: March 22, 2026, 3:56 p.m.